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ABSTRACT: Marine sponges are known for their use of biologically active
allelopathic compounds. With almost every species of sponge having been shown to
produce some chemical with medicinal properties, their survival is becoming
increasingly important. Current extraction methods used by research teams require a
large sample relative to the size of the sponge, which threatens the survival of the
organism. 1 Ptilocaulis sp., or the orange tree sponge, is known to produce guanidine
metabolites. This derivative has demonstrated biological activity against cell lines of
leukemia, uterine, and cervical cancer. 2• 3 In this study we have developed a method for
the chemical extraction of active metabolites from the ambient water containing a
sponge. Preliminary data suggests the metabolite was found both using the traditional
methods and using the water extraction. The organic extracts were used to test against
L1210 leukemia cells for biological activity.
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INTRODUCTION
Marine sponges have been a great source of medically relevant compounds
since their first use in the ancient world as anything from an analgesic to a cutaneous
applicable cough suppressant. In 1949 , Bergmann and Feeney started the derivation of
compounds from these natural resources with their discovery of three nucleosides from
a Caribbean sponge. 4 The sharp increase in using natural products for treatments or
cures in more serious illnesses over the last 50 years has created a need to extract these
chemicals with a greater yield and higher frequency. 5
Current extraction techniques involve procurement of a marine sponge either by
direct harvest from the sea or from a commercial vendor followed by a solid/liquid
extraction. The Heys group slightly altered an extraction method with dichloromethane
originally used by the Patil group on the sponge

Batzella sp. 6 The group completed a CH2 Ch:MeOH
(1:1) extraction on a freeze-dried sample of the
sponge and further extracted by triturating the red
solid with three solvents. The solvent fraction
containing the main guanidine metabolites, which
are the focus of this research, was the CH2 Ch
extract. 3
The sponge of interest in this study, Figure 1. The orange tree sponge,
Ptilocaulis spiculifer, we used in
Ptilocaulis spiculifer, the orange tree sponge shown this study.
in Figure 1, is native to the Caribbean. Although it
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is available for purchase in the United States, the scarcity of the sponge makes it
difficult to find. Crambe crambe is another sponge that has shown promise in medicine
for the secondary metabolites that this species produces, but it is found in the
Mediterranean. 7 Although not as rare, all marine sponge species that produce medically
relevant metabolites run the risk of being over harvested. Focusing on species like this
will make the results of such an alternative extraction that much more important for the
survival of the sponges. Metabolites produced by each species are similar, but
ptilomycaulin A has been shown to be the major metabolite of Ptilocaulis spiculifer,
which is the focus of this study. Metabolites of interest that Crambe crambe produce
are the family of crambescins and crambescidins, which are also mentioned in this
study and shown to be produced in smaller quantities by Ptilocaulis spiculifer.
Unfortunately, current extraction methods, hereby referred to as traditional

extraction methods, end in the loss of wildlife due to exposure to organic solvents and
maceration of the sample. Utilizing this method for treatment of the human population
creates a reliance on a non-renewable process that would not have the efficacy to
reproduce enough viable sponges to replace those lost to extraction. In order to extract
just one gram of the anticancer agent ET 743, it takes almost one metric ton (wet
weight) of the marine sponge E. turbinate. 4 These extraction methods also select for a
general group of molecules bearing similar physical properties (i.e. solubility), and
therefore the extract is not a pure sample of the desired metabolite. Purification of these
extracts often leads to sub milligram quantities of isolated metabolites using the
traditional methods.
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Due to the small quantities isolated by extraction, many of the miracle
compounds are currently being synthetically designed. These processes require
expensive reagents and produce large quantities of hazardous waste. 8 These synthetic
methods do generate a more pure product, but there are fallbacks. Not only do these
methods require a large amount of various reagents and waste disposal, but they also
require extended amounts of time, frequently more than 6 months of work for one
batch, and the yield is often less than 1% conversion from the initial reagents to the
product.
Ptilocaulis spiculifer and Crambe crambe are known to produce secondary
metabolites crambescidin-800 and crambescidin-816 (1, 2), batzelladines A and B (3,
4), and ptilomycaulin A (5), which are all examples of those allelopathic compounds

that have been isolated using the traditional extraction method (Figure 2). In particular,
ptilomycaulin A has a known biological activity against L1210 (lymphocytic leukemia)
cells, P388 (leukemia), KB (HeLa contaminant, carcinoma and papilloma), as well as
antifungal activity against Candida albicans and antiviral activity (HSV). 2• 3 Ptilocaulis
spiculifer was chosen because the major metabolite, as its name implies, is
ptilomycaulin A. We are most interested in this metabolite because it has a high activity
against cell lines mentioned above at low concentrations. Laboratory limitations made
it impossible to study the effects on fungal or viral targets. The KB cell line was not
chosen because it contained multiple strains of cancerous cells. P388 and L1210 both
served as viable options for the target in this research, but due to the difficult growth
environments necessary for P388, it was decided that the target would be the Ll210
cell line.
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Levels of IC-50, or half maximal inhibitory concentration, for each of the
inflictions are shown in Table 1. IC-50 generally refers to a way of measuring the
activity of agents in inhibiting different pathogens. 9 In this case, it specifically
measures the concentration of the compound at which fifty percent of the target cells
are immobilized or destroyed.

Table 1. Biological activity for ptilomycaulin A as reported by Heys et. al.

� 08

+-------------

� 0.6 +--------------

P388 (leukemia cells)

Ll210 (leukemia cells)

KB (HeLa cells)
Target

Candida albicans (fungus)

Herpes Simplex Virus

This project focuses on creating a more ecologically friendly way to extract
these chemicals that do not end in the loss of the organism. This could possibly mean a
lower financial input as well as a self-sufficient system with continual extraction for
higher yields. Many of the compounds of interest are allelopathic compounds meaning
they are secreted from the sponge to cease the growth of nearby organisms ensuring the
space necessary for the expansion of the sponge itself. 4 Due to the purpose of these
compounds, it is reasonable to assume that the metabolite would have a significant
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concentration in the waters surrounding the sponge. This makes liquid/liquid extraction
of the ambient waters a viable alternative to the traditional solid/ liquid extraction.
With the ambient water extraction, we propose it would be possible to have
Ptilocaulis spiculifer growing in a salt-water tank and use the water from a routine
water change to extract those compounds for application against 11210 leukemia cells.
Some of the known metabolites listed above are shown below in Figure 2.
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Figure 2. Known metabolites produced by Ptilocaulis spiculifer.
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EXPERIMENTAL SECTION
Extraction was completed using water from a tank that contained two sponges
of the species Ptilocaulis spiculifer. After extraction, the fraction was concentrated and
analyzed using liquid chromatography - mass spectrometry (LC-MS) and biological
assays. As mentioned before, ptilomycaulin A was originally thought to be the main
metabolite of this species. So, the ambient water extraction was derived based on the
traditional extraction method used for ptilomycaulin A specifically. Each process is
described in detail below.
When first working with the sponge, we also decided to complete the traditional
solid/ liquid extraction process with one of the sponge specimens in order to ensure the
presence of the chemical and also to verify the most efficient identification method of
the metabolites. This process is described in the Traditional Extraction section.
Traditional Extraction. A full red tree sponge (Ptilocaulis spiculifer; Aquacon) was

placed into a liquidizer with 1: 1 dichloromethane to methanol and the entire specimen
was ground up until segments of the organism resembled small shavings. The sample
was filtered and the liquid concentrated under vacuum and stored below -4 °C until
analysis.
Ambient Water Extraction. Approximately 200 mL dichloromethane was added to the

extractor to cover the lower transfer line (Figure 3). Marine tank water was then added
to the reservoir of the continuous liquid-liquid extractor until the DCM was pushed
over and filled the round bottom flask halfway. This point was reached with about 1 L
of tank water.
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The DCM was heated at reflux then condensed through the water sample
accumulating the organic metabolites in the round bottom flask with each pass.
Accumulation occurs in the round bottom because the compound does not evaporate
with the solvent and therefore the solvent is simply reused to continually extract the
compound from the sample on the left. Figure 4 shows a diagram of the movement of
solvent and compound using this glassware. Solvent was allowed to circulate through
the sample for at least 24-hours. The prolonged and continuous exposure with the
extraction

solvent

was

expected

to

give

the

highest

DCMw/o

Large
[Extraction)
Vessel

possible

yield

Phase Change:
Gas to liquid
Phase change:
Liquid to gas

,,;

DCMw/o
Compound

r DCMwt
Compound l
�

( Compound '\
Collection I
Round BottomJ

Heat applied to boil off
[solvent for recycling backJ
into extractor and
through sample

Figure 3. Glassware set up for the
overnight reflux of tank water with
dichloromethane for the liquid-liquid
extraction of organics.

Figure 4. Diagram illustrating the
extraction process of the compound
from the water sample. Green brackets
represent the round bottom in which the
compound is accumulated; blue
brackets represent the large partition of
the extraction glassware where the
sample and DCM interact. Red areas
show where the DCM flows, but the
compound does not; green areas shown
where the compound is present in the
DCM; the blue area represents the
water sample.
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from the water source. After extraction for 24 hours, the tank water sample was
replaced with another liter to continue collecting the compound from a fresh sample.
Therefore, each ambient water extraction sample was derived from 2 liters of the tank
water.
When the extraction was complete, the round bottom flask was removed from
the apparatus and its contents concentrated under vacuum. The concentrated oil was
stored below -4 ° C until preparation for analysis with LC-MS or a cytotoxicity assay.

Table 2. This table shows all of the known mass spectral data about the metabolites of
interest in this study. Included as well are physical properties of the compounds after
extraction or synthesis in other labs.
Reported
Exact Mass
Physical
Compound
Fragmentation
(amu)
Properties
None
801.62
Crambescidin-800
Yellow oil 11
817.61
None
Crambescidin-816
Proposed to be
the same as
above 10
655,637,609,474, Colorless gum6
Batzelladine A
768.58
350,332,304,114
318,302,274
Batzelladine B
738.59
Colorless,
amorphous
solid6
Ptilomycaulin A
786.18
None
No color3

LC-MSIUVMs.

A

liquid

chromatograph

with

electrospray

ionization-mass

spectrometry detection was used to analyze the samples for the presence of one of the
metabolites. Exact masses, fragmentation data, as well as physical properties can be
found in Table 2. Samples were prepared by dissolving the residue in the round bottom
flask with acetonitrile (MeCN). Each sample was eluted on a C 18 reverse phase column
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using a MeCN mobile phase. Samples were also detected using UVNis at wavelength
272 nm. Results are present in Figures 5 and 6 of the results section.
Cytotoxicity Assay. A Pierce LDH Cytotoxicity Assay Kit (Thermo Scientific) was used

with L1210 (lymphocytic leukemia) cells to analyze all samples. Samples were dried
under high vacuum to ensure an accurate mass of the mixtures.
Samples were then dissolved in 75:25 PBS:dimethyl sulfoxide (DMSO) for
final assay concentrations of 2X, lX and 1/2X (X=0.4 µg mL- 1), where IX is the IC-50
of ptilomycaulin A against L1210 leukemia cells, as cited by Heys et. al. 3 This
concentration was used because the initial hypothesis was that the extracted metabolite
would be ptilomycaulin A DMSO of equal volume to the highest volume used in the
extract dilutions, media, and 100% lysis were also measured for control purposes.
RESULTS AND DISCUSSION

Overall, the ambient water extraction method was successful in extracting
metabolites produced by the sponge from the surrounding water. Although the major
metabolite expected, ptilomycaulin A, from this sponge was not found, there is
evidence supporting the presence of crambescidin-816. Results from both LC-MS and
the cytotoxicity assays supported the presence of the crambescidin. Complete
characterization of the metabolites extracted was not possible within this lab. However,
using current literature with the results gathered here it was possible to determine the
major composition of the oil extract. Results showing this are discussed below.
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Extractions
For the traditional extraction method the extract had a dark orange color. This
was suspected to be mainly due to the orange color of the sponge. However, the
ambient water extraction yielded a yellow oil. It should be stressed that no part of the
sponge was collected in the extraction method, and that only water was used in the
extraction process. Therefore the color of the extract must come from something that
was extracted from the water.

LC-MS/UV/Vis
Using the traditional extraction method and the ambient water extraction, LC
MS and LC-UVNis measurements were taken to analyze the extracts. The full
chromatograms for both the traditional extraction and the ambient water extraction are
shown in Figures 4 and 5.
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Figure 4. The top chromatogram shows the total ion count over time for the
metabolites extracted by the traditional extraction method. The UV-Vis chromatogram
(272 nm) during the same time course is below the mass spectrum.
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Figure 5. This top chromatogram shows the MS total ion count from the extract
obtained using the ambient water extraction method. The UV-Vis chromatogram (272
nm) is included on the bottom chromatogram showing the scan during the same time
course.
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It is clear based on these spectra that there is a major metabolite extracted with
both methods that elutes at 5.1 minutes.
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Figure 6. Mass spectrum from the ambient water extraction at 5.155 minutes (the
elution time of the major metabolite from both the ambient water extraction and the
traditional extraction method).
Figure 6 shows the mass spectrum obtained at 5.155 minutes from the ambient
water extract, which had similar fragments to the traditional extraction sample; only
one was shown here. The major ion peak at 747.7 did not seem to match any
fragmentation suggested for ptilomycaulin A. However, there were possible
fragmentations for crambescidin 800, crambescidin 816, and batzelladine A that would
result in the peaks denoted above: the most likely of these are one of the crambescidin
compounds. Batzelladines are not as likely here because there are published
fragmentation patterns for both of the batzelladines and the other fragments, as listed in
Table 1, are not present in this chromatogram. In addition, the color of the batzelladines
do not match the yellow oil obtained from the ambient extraction method.
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Cytotoxicity Assay
Cell cytotoxicity was determined by comparing the cell death found in the
samples to the cell death when in the presence of lysis buffer, which was assumed to be
100% lysis.

120

-2X Sponge (0.8 µg/mL)

100

·-

- IX Sponge (0.4 µg/mL)

80 -1------------,lh91!��--------L---1/2X Sponge (0.2
µg/mL)

-Extract 1.1 (0.4 µg/mL)

60

-Extract 1.2 (0.4 µg/mL)

40

-Water after sponge death
(0.4 µg/mL)

DMSO Control

20
0

-Negative Control

I

2

3

4

Time (hours)

Figure 6. Cell cytotoxicity when comparing the activity of the extracts to that of 100%
cell lysis when cells were exposed to lysis buffer. Sponge samples denote samples
derived from the traditional extraction method. Extract 1.1 and 1.2 denote separate
extracts taken from tank water changes. DMSO served as a control because the extracts
were dissolved in DMSO, which is known to have a slight cytotoxicity effect. Error
bars show 5% error.
Sponge samples denote sample that were obtained using the traditional
extraction method. These were expected to show cell lysis due to the use of this method
in literature, and thus they served as positive controls for the extraction samples.
Concentrations noted as 2X, IX and l/2X (X=0.4 µg mL-1), correspond to the CC
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(cytotoxic concentration)-50 (CC-50 = lX) of ptilomycaulin A against L1210 leukemia
cells as cited by Badinger et. al. Again, as mentioned in the experimental section, the
ptilomycaulin A CC-50 was used because the initial hypothesis was that ptilomycaulin
A would be extracted from the ambient water. Extracts 1.1 and 1.2 are samples derived
from the ambient water extraction method. The negative control was a salt-water
sample taken from a fish tank. This was considered to be a good control because the
tank in which the sponges were held were pre-treated with three fish and two hermit
crabs to prepare the water for the sponges: as the data shows, the presence of the
wildlife did not add cytotoxic activity to the extraction samples.
CONCLUSIONS/ FUTURE WORK
The identity of the compound could not be completely characterized, however it
is proposed that the most likely metabolite isolated was crambescidin 816. Coffee et. al.
report that crambescidin 800 is a yellow oil when in the salt form, but the only
difference between crambescidin 800 and crambescidin 816 is a hydroxyl group, so it is
proposed that the color of crambescidin 816 will also be yellow; the same color as the
oil extract obtained using the ambient water extraction method.11 While the color of the
extracts do not provide the compounds identity, the activity of the extracts were much
higher than expected for ptilomycaulin A.
In addition to the color of the compound extracted, Jares-Erijman et. al.
reported crambescidin 816 as the most abundant of all of the crambescidin
metabolites. 12 In another year, Jares-Erijman et. al. reported that the hydroxyl group
not present on ptilomycaulin A and crambescidin 800 that is present on crambescidin
816 infers greater cytotoxicity effects. 13 This is relevant because the cytotoxicity levels
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noted in the assays were much higher at the 1/2X concentration than literature reports
for ptilomycaulin A. Therefore, due to the color of the extract, the absence of fragments
from the batzelladines and ptilomycaulin A, and the cytotoxicity activity of the
compound, it is proposed that crambescidin 816 is the metabolite extracted using the
ambient water extraction method. Further testing to fully determine the presence of this
metabolite would be purification by preparation chromatography coupled with single
and multi-dimensional, single- and multi-nuclear NMR analysis. NMR data for all
metabolites already exist in literature, and it would therefore be a viable determination
of the metabolite.
Further application of this method could be used for a large-scale operation to
optimize extraction. For example, a large tank could have a continual flow of water to
an extraction chamber where the compound is extracted and further processed while the
water that is extracted could be returned to the tank. The organic extraction would act
as a carbon filter that is commonly present in many saltwater tanks. Over the amount if
time it takes for synthesis to be completed, it would be interesting to compare the
amount of compound extracted from the water to that of the yield of the synthesis.
Actual application of the compound to cancer in a murine model system would
be the next step after purification. Peptoid drug delivery systems have been shown very
effective in the delivery of guanidinium compounds to the nucleus. 14 Having an
efficient extraction system with a constant extraction of product like this will make the
isolation of these biologically relevant, allelopathic compounds much easier, more
affordable, and with little to no hazardous by-product. Metabolites like the ones listed
are not the only allelopathic compounds produced by marine organisms. Application of
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this water extraction system could potentially reach any marine organism with an
allelopathic protection mechanism accomplishing environmentally friendly extraction
of natural marine compounds. Changing the solvent used for extraction could also
change the metabolite isolated creating numerous options for optimizing this method
for different metabolites, or groups of metabolites, to be extracted. Although the
original target of ptilomycaulin A was not believed to be extracted, this method was
successful in extracting the allelopathic metabolites of Ptilocaulis spiculifer from the
ambient water.
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